Logo for Veru Inc

Veru Investor Relations Material

Latest events

Logo for Veru Inc

Q3 2024

Veru
Logo for Veru

Q3 2024

8 Aug, 2024
Logo for Veru

Q2 2024

8 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Veru Inc

Access all reports
Segment Data
Access more data
Net revenue by
Category
U.S. prescription channel
Global public health sector
Other
Expenses by
Financials
Veru, Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company's lead product is currently in Phase III clinical trials, and it has also initiated Phase II trials with additional compounds targeting other therapeutic areas. Veru's clinical development pipeline includes two compounds formulated with cationic polymers, one of which was designed to improve the delivery of a select class of cancer therapeutics. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.